AI-Driven Decentralized Disease Surveillance and Diagnostic Platform

A decentralized, AI-powered disease surveillance and diagnostic platform leveraging collapsible fluid collection devices with integrated microfluidic chips and wireless communication capabilities for real-time sample analysis and remote monitoring.

The original patent addressed the need for early diagnosis in medical diagnostic tests, particularly in communicable diseases. However, it did not provide a comprehensive solution for decentralized disease surveillance and remote monitoring. The new inventive concept solves this problem by integrating AI-driven analytics, microfluidic chips, and wireless communication capabilities into a decentralized platform, enabling real-time disease monitoring and predictive modeling.

The AI-driven decentralized disease surveillance and diagnostic platform consists of a network of collapsible fluid collection devices, each equipped with a microfluidic chip for real-time sample analysis and wireless communication capabilities for transmitting results to a centralized database. The platform utilizes machine learning algorithms to analyze data from the devices, identify trends and patterns, and generate predictive models for disease outbreaks. Additionally, the platform includes an AI-powered diagnostic engine for interpreting results and providing personalized treatment recommendations. The system enables remote, telemedicine-based disease diagnosis and continuous bodily fluid monitoring through wearable, implantable, or injectable devices.

The new inventive concept introduces the integration of AI-driven analytics, microfluidic chips, and wireless communication capabilities into a decentralized disease surveillance and diagnostic platform, which is not present in the original patent. The inventive step lies in the combination of these components to enable real-time disease monitoring, predictive modeling, and personalized treatment recommendations.

Alternative embodiments of the platform could include the use of different types of microfluidic chips, various wireless communication protocols, or integration with existing electronic health record systems. Variations could also include the development of specialized devices for specific diseases or applications, such as infectious disease monitoring or cancer diagnosis.

The AI-driven decentralized disease surveillance and diagnostic platform has significant commercial potential in the healthcare industry, particularly in the fields of infectious disease monitoring, personalized medicine, and remote patient monitoring. The platform could be marketed to healthcare providers, research institutions, and government agencies, with potential applications in disease outbreak response, clinical trials, and public health surveillance.